TIANJIN KINGYORK PHARMACEUTICALS CO., LTD.

Booth C5

No. 221 Huanghai Road, TEDA, Tianjin,300457，CHINA

Tianjin KingYork Pharmaceuticals Co., Ltd.
a subsidiary of Tianjin Tianyao Pharmaceuticals Co., Ltd., is situated within the FDF Base, covering 40.36 acres. With a total investment of USD 17 million, the company manufactures 17 dosage forms, including injections, ointments, creams, capsules, tablets, lyophilized powders for injection, eye drops, inhalations, and peritoneal dialysis solutions.
Production Capacity Highlights:5 billion oral solid tablets annually；300 million units of ointments/creams annually；524 million injections annually.
The company holds over 200 registration certificates approved by CHINA’s National Medical Products Administration (NMPA). Notably, its Methylprednisolone Tablets, Prednisone Tablets, Celecoxib Capsules, and Methylprednisolone Sodium Succinate for Injection have received USFDA ANDA approval.